CEA |
n/n |
Clear: Dog tested negative for the Collie Eye Anomaly mutation. |
CEA/CEA |
Affected: Dog carries two copies of the Collie Eye Anomaly mutation and will be affected by the disorder. Dog will always pass on a copy of the CEA mutation to any offspring. |
n/CEA |
Carrier: Dog carries one copy of the Collie Eye Anomaly mutation and could pass the mutation on to any offspring. |
CN |
n/n |
Clear: Dog tested negative for the Cyclic Neutropenia mutation. |
CN/CN |
Affected: Dog has two copies of the Cyclic Neutropenia mutation, and is affected by the disorder. |
n/CN |
Carrier: Dog has 1 copy of the Cyclic Neutropenia mutation. The dog is not affected, but can pass this mutation on to any offspring. |
Degenerative Myelopathy often referred to as DM, and sometimes CDRM - read more HERE |
n/n |
Clear: Dog is negative for the Degenerative Myelopathy mutation. |
DM/DM |
At Risk: Dog has a significantly higher risk of developing DM, and will always pass on a copy of the mutation to its offspring. |
n/DM |
Carrier: Dog carries one copy of the mutation associated with Degenerative Myelopathy, and could pass on the mutation to any offspring. |
DMS |
023:01|023:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
002:01|023:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
002:01|002:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
023:01|023:01|Aabb |
Dog is at low risk of developing Dermatomyositis. |
002:01|023:01|Aabb |
Dog is at low risk of developing Dermatomyositis. |
002:01|002:01|Aabb |
Dog is at low risk of developing Dermatomyositis. |
023:01|023:01|aaBb |
Dog is at low risk of developing Dermatomyositis. |
002:01|023:01|aaBb |
Dog is at low risk of developing Dermatomyositis. |
002:01|002:01|aaBb |
Dog is at low risk of developing Dermatomyositis. |
023:01|023:01|AaBb |
Dog is at low risk of developing Dermatomyositis. |
002:01|023:01|AaBb |
Dog is at low risk of developing Dermatomyositis. |
002:01|002:01|AaBb |
Dog is at low risk of developing Dermatomyositis. |
AAbbcc |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|023:01|AaBB |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|002:01|AaBB |
Dog is at moderate risk of developing Dermatomyositis. |
aaBBcc |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|023:01|aaBB |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|002:01|aaBB |
Dog is at moderate risk of developing Dermatomyositis. |
AaBBcc |
- |
002:01|023:01|AaBB |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|002:01|AaBB |
Dog is at a high risk of developing Dermatomyositis. |
AABbcc |
- |
002:01|023:01|AABb |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|002:01|AABb |
Dog is at a high risk of developing Dermatomyositis. |
023:01|023:01|AABb |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|023:01|AaBB |
Dog is at a high risk of developing Dermatomyositis. |
002:01|002:01|AABB |
Dog is at a high risk of developing Dermatomyositis. |
002:01|015:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
002:01|015:01|Aabb |
Dog is at low risk of developing Dermatomyositis. |
002:01|015:01|AaBb |
Dog is at low risk of developing Dermatomyositis. |
Aabbcc |
Dog is at low risk of developing Dermatomyositis. |
002:01|015:01|aaBB |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|002:01|Aabb |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|002:01|AAbb |
Dog is at moderate risk of developing Dermatomyositis. |
002:01|015:01|AAbb |
Dog is at moderate risk of developing Dermatomyositis. |
006:01|006:01|aaBb |
Dog is at low risk of developing Dermatomyositis. |
006:01|015:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
|
Dog is at moderate risk of developing Dermatomyositis. |
006:01|002:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
015:01|015:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
023:01|015:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
006:01|002:01|Aabb |
Dog is at low risk of developing Dermatomyositis. |
006:01|015:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
006:01|006:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
015:01|002:01|AaBb |
Dog is at low risk of developing Dermatomyositis. |
015:01|002:01|AABb |
Dog is at low risk of developing Dermatomyositis. |
002:01|023:01|AAbb |
Dog is at low risk of developing Dermatomyositis. |
023:01|015:01|AaBb |
Dog is at low risk of developing Dermatomyositis. |
006:01|006:01|Aabb |
Dog is at low risk of developing Dermatomyositis. |
002:01|015:01|aaBb |
Dog is at low risk of developing Dermatomyositis. |
023:01|015:01|aabb |
Dog is at low risk of developing Dermatomyositis. |
006:01|002:01|AAbb |
Dog is at moderate risk of developing Dermatomyositis. |
015:01|015:01|AAbb |
Dog is at moderate risk of developing Dermatomyositis. |
023:01|023:01|AAbb |
Dog is at moderate risk of developing Dermatomyositis. |
015:01|002:01|AAbb |
Dog is at moderate risk of developing Dermatomyositis. |
023:01|015:01|Aabb |
Dog is at low risk of developing Dermatomyositis. |
MDR1 |
n/n |
Clear: Only normal unaltered allele detected. Dog should not exhibit any sensitivity to ivermectin or other drugs associated with this disorder. |
M1/M1 |
Affected: Homozygous for MDR1 and dog will always pass the gene on to offspring. Will experience sensitivity to ivermectin or other associated drugs. |
n/M1 |
Carrier:Dog carries one copy of the mutation and may pass it on to offspring. May experience some sensitivity to ivermectin or other associated drugs |